Thus, it is possible that proinflammatory cytokines such as IL-6 and chemokines as well as complement activation with subsequent C5a and C3a release during SARS-CoV-2 infections may result in MC degranulation and development of urticaria in COVID-19 patients. This evidence concerns the gene IL6 and COVID-19.